Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew M Scott

Showing results (201-210 of 395) with videos related to

Pageof 40
Sort By:
EJNMMI Research|June 12, 2012
Pharmacodynamic analysis of tumour perfusion assessed by 15O-water-PET imaging during treatment with sunitinib malate in patients with advanced malignanciesAndrew M Scott, Paul L Mitchell, Graeme O'Keefe, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|August 18, 2015
First in human nanotechnology doxorubicin delivery system to target epidermal growth factor receptors in recurrent glioblastomaJames R Whittle, Jason D Lickliter, Hui K Gan, et al.
Cancers|August 7, 2021
Cell-Extrinsic Differentiation Block Mediated by EphA3 in Pre-Leukaemic Thymus Contributes to Disease ProgressionAdriana C Pliego Zamora, Hansini Ranasinghe, Jessica E Lisle, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 5, 2025
Polymyalgia rheumatica patients presenting with atypical clinical features still exhibit characteristic <sup>18</sup>F-FDG PET/CT findingsEmily Martin, Christopher R McMaster, Aurora Mt Poon, et al.
Biorxiv : the Preprint Server for Biology|October 31, 2023
Detection of EGFR and its Activity State in Plasma CD63-EVs from Glioblastoma Patients: Rapid Profiling using an Anion Exchange Membrane SensorNalin H Maniya, Sonu Kumar, Jeffrey L Franklin, et al.
Cancers|November 12, 2013
Glioma Specific Extracellular Missense Mutations in the First Cysteine Rich Region of Epidermal Growth Factor Receptor (EGFR) Initiate Ligand Independent ActivationSusie I Ymer, Sameer A Greenall, Anna Cvrljevic, et al.
European Urology|April 23, 2026
Performance of [<sup>89</sup>Zr]girentuximab PET/CT in Predicting the Presence of Any Renal Malignancy: A Reanalysis of the ZIRCON TrialAboubacar Kaba, Pratik Kanabur, Jeremie Calais, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 4, 2005
Assessment of the role of FDG PET in the diagnosis and management of children with refractory epilepsyGlenn P Ollenberger, Amanda J Byrne, Salvatore U Berlangieri, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 13, 2018
Accuracy of Dose Calibrators for <sup>68</sup>Ga PET Imaging: Unexpected Findings in a Multicenter Clinical Pretrial AssessmentDale L Bailey, Michael S Hofman, Nicholas J Forwood, et al.
European Journal of Pharmacology|February 15, 2011
Antibody inhibiting enzymatic activity of tumour-associated carbonic anhydrase isoform IXMargarita T Murri-Plesko, Alzbeta Hulikova, Egbert Oosterwijk, et al.
Pageof 40

Showing results (201-210 of 395) with videos related to

Sort By:
Pageof 40
EJNMMI Research|June 12, 2012
Pharmacodynamic analysis of tumour perfusion assessed by 15O-water-PET imaging during treatment with sunitinib malate in patients with advanced malignanciesAndrew M Scott, Paul L Mitchell, Graeme O'Keefe, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|August 18, 2015
First in human nanotechnology doxorubicin delivery system to target epidermal growth factor receptors in recurrent glioblastomaJames R Whittle, Jason D Lickliter, Hui K Gan, et al.
Cancers|August 7, 2021
Cell-Extrinsic Differentiation Block Mediated by EphA3 in Pre-Leukaemic Thymus Contributes to Disease ProgressionAdriana C Pliego Zamora, Hansini Ranasinghe, Jessica E Lisle, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 5, 2025
Polymyalgia rheumatica patients presenting with atypical clinical features still exhibit characteristic <sup>18</sup>F-FDG PET/CT findingsEmily Martin, Christopher R McMaster, Aurora Mt Poon, et al.
Biorxiv : the Preprint Server for Biology|October 31, 2023
Detection of EGFR and its Activity State in Plasma CD63-EVs from Glioblastoma Patients: Rapid Profiling using an Anion Exchange Membrane SensorNalin H Maniya, Sonu Kumar, Jeffrey L Franklin, et al.
Cancers|November 12, 2013
Glioma Specific Extracellular Missense Mutations in the First Cysteine Rich Region of Epidermal Growth Factor Receptor (EGFR) Initiate Ligand Independent ActivationSusie I Ymer, Sameer A Greenall, Anna Cvrljevic, et al.
European Urology|April 23, 2026
Performance of [<sup>89</sup>Zr]girentuximab PET/CT in Predicting the Presence of Any Renal Malignancy: A Reanalysis of the ZIRCON TrialAboubacar Kaba, Pratik Kanabur, Jeremie Calais, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 4, 2005
Assessment of the role of FDG PET in the diagnosis and management of children with refractory epilepsyGlenn P Ollenberger, Amanda J Byrne, Salvatore U Berlangieri, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 13, 2018
Accuracy of Dose Calibrators for <sup>68</sup>Ga PET Imaging: Unexpected Findings in a Multicenter Clinical Pretrial AssessmentDale L Bailey, Michael S Hofman, Nicholas J Forwood, et al.
European Journal of Pharmacology|February 15, 2011
Antibody inhibiting enzymatic activity of tumour-associated carbonic anhydrase isoform IXMargarita T Murri-Plesko, Alzbeta Hulikova, Egbert Oosterwijk, et al.
Pageof 40